REVB - REVELATION BIOSCIENCES, INC.
1.24
-0.010 -0.806%
Share volume: 36,194
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$1.25
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 09-23-2024 | 09-23-2024 | 11-08-2024 | 03-06-2025 | 05-08-2025 | 11-06-2025 | 02-26-2026 | |
| Cash flow financing | 5.417 M | 0.000 | 3.743 M | 3.688 M | 0.000 | 9.124 M | -41.166 K | |
| Other financing cash flows | 127.000 | 0.000 | 3.743 M | 3.688 M | 0.000 | 9.124 M | -41.166 K | |
| Cash flow | 2.560 M | 0.000 | -5.532 M | -42.034 K | -2.794 M | 0.000 | 0.000 | |
| Net income | -2.681 M | -8.390 M | -2.242 M | -1.726 M | -2.051 M | -1.907 M | -2.511 M | |
| Depreciation | 6.262 K | 7.220 K | 7.220 K | 7.221 K | 7.221 K | 6.765 K | 5.852 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -19.172 K | 0.000 | -17.688 K | 17.689 K | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 19.172 K | 0.000 | 17.688 K | -17.689 K | 0.000 | 0.000 | 0.000 | |
| Cash Change | 2.560 M | -2.479 M | -5.532 M | -42.034 K | -2.794 M | 7.535 M | -2.008 M |